Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
Unchalee Permsuwan,1,2 Krit Leemasawat,3 Poukwan Arunmanakul1,2,4 1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Center for Medical and Health Technology Assessment (CM-HTA), Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai Un...
Saved in:
| Main Authors: | Permsuwan U, Leemasawat K, Arunmanakul P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/adding-tolvaptan-in-the-inpatient-treatment-for-patients-with-heart-fa-peer-reviewed-fulltext-article-CEOR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Importance of early use of tolvaptan in hyponatremic acutely decompensated heart failure patients, a retrospective study
by: Rarsari Soerarso, et al.
Published: (2025-01-01) -
Severe tolvaptan-associated hyperglycemia: a case report
by: Huihuan Sun, et al.
Published: (2025-07-01) -
Factors associated with readmission after long-term administration of tolvaptan in patients with congestive heart failure
by: Shoko Yamashita, et al.
Published: (2024-11-01) -
Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
by: Shunsuke Tamaki, et al.
Published: (2020-06-01) -
Budget Impact and Cost–Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand
by: Arunmanakul P, et al.
Published: (2025-02-01)